The artificial disc replacement market is expected to witness robust CAGR due to increase in the prevalence of osteoporosis and surge in global geriatric population. Rise in the incidence and prevalence of degenerative diseases and increase in the demand for minimally invasive surgeries, less re-operation rate, and better clinical trial results might fuel the global artificial disc market growth over the forecast period. Furthermore, new product innovation, technological development for new products, an increase in R&D activities for multi-level artificial disc might boost the artificial disc market over the forecast period. However, high procedure cost, stringent regulatory policies, expensive devices, and unfavourable reimbursement policies might hamper the growth of artificial disc market over the forecast period.A sample of this report is available upon request @
[URL]https://www.precisionbusinessinsights.com/market-reports/global-artificial-disc-market/#ulp-4H8Z4LpNMLEuOnnx[/URL]
The global artificial disc market is segmented on the basis of product type, material type, and end user
Based on product type, the artificial disc market has been segmented into following:
Cervical disc
Lumbar disc
Based on the material type, the artificial disc market has been segmented into following:
Metal on metal
Metal on the biopolymer
Based on the end user, the artificial disc market has been segmented into following:
Hospitals
Orthopaedic Clinics
Ambulatory surgical centers
To view TOC of this report is available upon request @
[URL]https://www.precisionbusinessinsights.com/market-reports/global-artificial-disc-market/#ulp-c654SbFYO64MsOhu[/URL]
The global artificial disc market is in developing stage. Launch of new products, technological development, collaborations, acquisitions, and mergers are the key strategies followed by various medical device companies to increase revenue share in the global artificial disc market. For instance, in 2013, Zimmer Biotech acquired LDR holdings to launch Mobi-C in the U.S. cervical market. Similarly, in September 2012, Globus Medical, Inc. announced that the Food and Drug Administration (FDA) has granted premarket approval for the Secure-C cervical artificial disc. The technological developments in the artificial discs enabled better translational and rotational movements, stability of implant for a long time, minimally invasive surgery and improvement in Quality adjusted life year.
Need more information about this report @
[URL]https://www.precisionbusinessinsights.com/market-reports/global-artificial-disc-market/#ulp-14mlyhjMGhVjZqa3[/URL]
Some of the key players in the global artificial disc market are Medtronic (U.S.), Globus Medical Inc. (U.S.), Johnson and Johnson Services Inc.,(DePuy Synthes) (U.S.), NuVasive Inc. (U.S.), Zimmer-Biomet (U.S.), Stryker Corporation (U.S.), Aesculap Implant System, LLC (U.S.), Alphatec Spine Inc. (U.S.), Smith & Nephew (U.K.), Orthovita Inc. (U.S.), Synthes Holding AG (U.S.), LDS Spine (U.S.), and Spinal Kinetics Inc. (U.S.) to name a few.
Precision Business Insights
Email: sales@precisionbusinessinsights.com
Toll Free(US): +1-866-598-1553